Endothelial KLF4 Loss Identified as Key Driver of Blood-Brain Barrier Breakdown and Age-Related Cognitive Decline
核心洞察
Researchers at University Hospitals (搜索) and Case Western Reserve University have identified KLF4 (搜索), a protein produced by blood-brain barrier endothelial cells, as a critical factor in age-related cognitive decline (搜索).
Loss of endothelial KLF4 (搜索) accelerated blood-brain barrier degradation, reduced brain blood vessels, and led to oxidative damage, neuroinflammation, and cognitive impairment in mouse models.
Single-cell RNA sequencing revealed disrupted immune response and barrier integrity pathways, explaining KLF4 (搜索)'s broad effects on brain health during aging.
A research team led by Andrew A. Pieper, MD, PhD, at University Hospitals (搜索) and Case Western Reserve University has pinpointed the loss of a single protein—KLF4 (搜索)—in the endothelial cells lining the brain's blood vessels as a central mechanism driving age-related blood-brain barrier (BBB) breakdown and subsequent cognitive decline. The findings, published in Proceedings of the National Academy of Sciences, open a new therapeutic avenue for preserving brain health during aging.
The blood-brain barrier is a protective structure composed of tightly packed endothelial cells that seal the interface between the bloodstream and the brain. This living barrier blocks harmful substances and pathogens, clears metabolic waste, and adjusts blood flow to active brain regions. Scientists have long observed that BBB functions deteriorate with age, but the molecular trigger setting this process in motion had remained elusive—until now.
KLF4 (搜索) at the Center of Barrier Integrity
"At the center of our findings is a protein called KLF4 (搜索), which is produced by the endothelial cells that line the blood-brain barrier. As people age, endothelial cells lose their ability to generate KLF4," said Pieper, who holds the University Hospitals (搜索) Morley-Mather Chair of Neuropsychiatry and serves as the Rebecca E. Barchas, MD, DLFAPA, Professor of Translational Psychiatry at Case Western Reserve University.
To investigate the consequences of KLF4 (搜索) loss, the researchers employed advanced two-photon microscopy, a technique enabling real-time observation of living brain tissue and blood vessels across the lifespan of mice. They found that accelerating the loss of KLF4 in endothelial cells also accelerated aging-related BBB degradation and cognitive decline.
The effects were striking: loss of KLF4 (搜索) rendered the blood-brain barrier leaky, reduced the number of small blood vessels in the brain, and impaired the barrier's ability to match blood flow with neuronal activity. Even in middle-aged mice, these vascular changes were followed by oxidative brain damage, neuroinflammation, nerve cell injury, anxiety, and cognitive decline—features typically associated with much older animals.
"Loss of endothelial cell KLF4 (搜索) accelerated every key aspect of brain aging that we measured," Pieper noted. "This suggests that therapies designed to preserve or restore KLF4 function in endothelial cells may help prevent age-related deterioration of the blood-brain barrier and the cognitive decline that follows."
Genetic Programs Reveal Broader Impact
To understand why KLF4 (搜索) exerts such wide-ranging effects, the team turned to single-cell RNA sequencing, which reads gene activity on a cell-by-cell basis. The analysis revealed disrupted pathways tied to immune response and blood-brain barrier integrity, explaining how the loss of a single protein could influence multiple facets of brain aging rather than affecting only one isolated process.
The finding provides researchers with a clearer target for future neuroprotective treatments—therapies designed to defend brain cells from damage. The next critical questions are why KLF4 (搜索) declines with age and how its activity might be safely strengthened. If those questions can be answered, the work could help guide drug development aimed at preserving the blood-brain barrier and slowing cognitive decline in aging populations.
Pieper also serves as director of the Brain Health Medicines Center at the Harrington Discovery Institute at University Hospitals (搜索) and is a psychiatrist and investigator in the Louis Stokes VA Geriatric Research Education and Clinical Center. The study was conducted by a research group from University Hospitals, Case Western Reserve University, and the Louis Stokes Cleveland VA Medical Center.